{"created":"2023-06-19T10:43:40.790210+00:00","id":3950,"links":{},"metadata":{"_buckets":{"deposit":"2bea45e5-8ef6-49e6-93e5-bf8a3e7ef6dd"},"_deposit":{"created_by":11,"id":"3950","owners":[11],"pid":{"revision_id":0,"type":"depid","value":"3950"},"status":"published"},"_oai":{"id":"oai:shiga-med.repo.nii.ac.jp:00003950","sets":["30:204:205"]},"author_link":["8255","8258","696","6959","8248","6759","844","8250","8259","8567","8253","8247","8568","8251"],"item_4_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2021-06-22","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{},{"bibliographic_title":"HPB : the official journal of the International Hepato Pancreato Biliary Association","bibliographic_titleLang":"en"}]}]},"item_4_creator_3":{"attribute_name":"著者別名","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"飯田, 洋也"}],"nameIdentifiers":[{},{},{}]},{"creatorNames":[{"creatorName":"谷, 眞至"}],"nameIdentifiers":[{},{},{}]},{"creatorNames":[{"creatorName":"前平, 博充"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"森, 治樹"}],"nameIdentifiers":[{},{}]}]},"item_4_description_14":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"pdf","subitem_description_type":"Other"}]},"item_4_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Background:\nWe aimed to investigate whether a novel biomarker incorporating albumin, lymphocytes, and CRP can predict the prognosis for hepatocellular carcinoma (HCC) after hepatectomy. ","subitem_description_type":"Abstract"},{"subitem_description":"Methods:\nBetween January 2011 and December 2013, 384 patients who underwent hepatectomy in four university hospitals in Japan were investigated as a discovery cohort. The CRP-Albumin-Lymphocyte (CALLY index) was defined as (Albumin × Lymphocyte)/(CRP × 104). Patients with a CALLY index ≥5 (n = 200) were compared to those with an index <5 (n = 184). Next, validation was performed using 267 patients from three other university hospitals (external validation cohort). ","subitem_description_type":"Abstract"},{"subitem_description":"Results:\nThe number of TNM Stage III and IV patients was significantly higher in the CALLY <5 group than the ≥5 group (p = 0.003). There was a significant difference in the 5-year survival rate (CALLY ≥5: 71% vs. <5: 46%; p < 0.001). Multivariate analysis identified the CALLY index as an independent factor of overall survival. Similarly, there was a significant difference in the 5-year survival rate between the CALLY ≥5 (73%) and <5 (48%) groups (p < 0.001), and the CALLY index was identified as an independent prognostic factor in the external validation cohort. ","subitem_description_type":"Abstract"},{"subitem_description":"Conclusion:\nThe CALLY index derived from CRP, albumin, and lymphocyte values is a promising predictive biomarker for postoperative prognosis of patients with HCC. ","subitem_description_type":"Abstract"}]},"item_4_description_42":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"Journal Article","subitem_description_type":"Other"}]},"item_4_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Elsevier B.V."}]},"item_4_relation_10":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"34244053","subitem_relation_type_select":"PMID"}}]},"item_4_relation_11":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"10.1016/j.hpb.2021.06.414"}],"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1016/j.hpb.2021.06.414","subitem_relation_type_select":"DOI"}}]},"item_4_rights_12":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"© 2021 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved. "}]},"item_4_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1477-2574","subitem_source_identifier_type":"ISSN"}]},"item_4_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"IIDA, Hiroya"}],"nameIdentifiers":[{},{},{}]},{"creatorNames":[{"creatorName":"TANI, Masaji"}],"nameIdentifiers":[{},{},{}]},{"creatorNames":[{"creatorName":"KOMEDA, Koji"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"NOMI, Takeo"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"MATSUSHIMA, Hideyuki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"TANAKA, Shogo"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"UENO, Masaki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"NAKAI, Takuya"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"MAEHIRA, Hiromitsu"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"MORI, Haruki"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"MATSUI, Kosuke"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"HIROKAWA, Fumitoshi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"KAIBORI, Masaki"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"KUBO, Shoji"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2022-06-22"}],"displaytype":"detail","filename":"j.hpb.2021.06.414.pdf","filesize":[{"value":"1.8 MB"}],"format":"application/pdf","license_note":"© 2021 International Hepato-Pancreato-Biliary Association Inc. \nPublished by Elsevier Ltd. All rights reserved. ","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"j.hpb.2021.06.414","url":"https://shiga-med.repo.nii.ac.jp/record/3950/files/j.hpb.2021.06.414.pdf"},"version_id":"10d2a9d9-2ec9-4b4f-928f-2044335f0c43"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Hepatocellular Carcinoma","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Non-invasive prognostic biomarker","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Hepatectomy","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"CALLY index","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma."}]},"item_type_id":"4","owner":"11","path":["205"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-07-21"},"publish_date":"2021-07-21","publish_status":"0","recid":"3950","relation_version_is_last":true,"title":["Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma."],"weko_creator_id":"11","weko_shared_id":-1},"updated":"2023-06-19T11:22:40.078880+00:00"}